New mechanism that shields persister tumor cells from immune system identified
Cancer therapies do not always succeed in eliminating tumor cells. Some of these cells enter a state of senescence—a latent, ...
News Medical1h
T-DM1 reduces long-term risk of death in HER2-positive breast cancer patients
In patients with high-risk HER2-positive breast cancer, post-surgery, or adjuvant, treatment with trastuzumab emtansine (T-DM1) reduced the long-term risk of death or invasive disease by 46% and ...
A tiny anticancer weapon: Nano-sized particles trigger tumor cell self-destruction
A new twist on a decades-old anticancer strategy has shown powerful effects against multiple cancer types in a preclinical ...
News Medical on MSN18h
Pancreatic cancer insights: How pORG classifications predict survival and guide treatment
Researchers identify distinct molecular and immune profiles that impact the prognosis of patients with metastatic pancreatic ductal adenocarcinoma.